Literature DB >> 19502796

Lung cancer-associated JmjC domain protein mdig suppresses formation of tri-methyl lysine 9 of histone H3.

Yongju Lu1, Qingshan Chang, Yadong Zhang, Kevin Beezhold, Yon Rojanasakul, Hongwen Zhao, Vince Castranova, Xianglin Shi, Fei Chen.   

Abstract

Lung cancer is the most common cancer worldwide, accounting for 1.3 million cancer deaths annually. Despite extensive studies over the past decade, the detailed mechanism about the initiation and development of the lung cancer is still elusive. In the present report, we showed that overexpression of mdig is a common feature of the non-small cell lung cancer. Gene silencing or overexpression of mdig revealed that mdig is involved in demethylation of tri-methyl lysine 9 on histone H3, leading to an increase in ribosomal RNA expression. The transcriptional regulation of ribosomal RNA gene by mdig is achieved through abrogating tri-methyl lysine 9 on histone H3 and enhancing RNA polymerase I occupancy in the promoter region of the ribosomal RNA gene as demonstrated by chromatin immunoprecipitation. The pronounced expression of mdig in lung cancer tissues but not normal lung tissues, thus, suggests that mdig possesses oncogenic property through antagonizing tri-methyl lysine 9 on histone H3 and promoting ribosomal RNA synthesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19502796     DOI: 10.4161/cc.8.13.8927

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  49 in total

Review 1.  The small members of the JMJD protein family: Enzymatic jewels or jinxes?

Authors:  Sangphil Oh; Sook Shin; Ralf Janknecht
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-04-26       Impact factor: 10.680

Review 2.  Inhibitors of Protein Methyltransferases and Demethylases.

Authors:  H Ümit Kaniskan; Michael L Martini; Jian Jin
Journal:  Chem Rev       Date:  2017-03-24       Impact factor: 60.622

3.  From biological mechanisms to clinical implications: the role of mineral dust-induced gene in lung cancers.

Authors:  Jianjun Zhang; Hongwen Zhao
Journal:  J Thorac Dis       Date:  2017-05       Impact factor: 2.895

4.  Histone demethylase JMJD2B and JMJD2C induce fibroblast growth factor 2: mediated tumorigenesis of osteosarcoma.

Authors:  Xiaojiang Li; Shanshan Dong
Journal:  Med Oncol       Date:  2015-01-31       Impact factor: 3.064

5.  Mdig, a lung cancer-associated gene, regulates cell cycle progression through p27(KIP1).

Authors:  Dan Ma; Dan Guo; Wei Li; Hongwen Zhao
Journal:  Tumour Biol       Date:  2015-04-09

6.  Carcinogenic metalloid arsenic induces expression of mdig oncogene through JNK and STAT3 activation.

Authors:  Jiaying Sun; Miaomiao Yu; Yongju Lu; Chitra Thakur; Bailing Chen; Ping Qiu; Hongwen Zhao; Fei Chen
Journal:  Cancer Lett       Date:  2014-01-14       Impact factor: 8.679

7.  CRISPR-Cas9 gene editing causes alternative splicing of the targeting mRNA.

Authors:  Qian Zhang; Yao Fu; Chitra Thakur; Zhuoyue Bi; Priya Wadgaonkar; Yiran Qiu; Liping Xu; M'Kya Rice; Wenxuan Zhang; Bandar Almutairy; Fei Chen
Journal:  Biochem Biophys Res Commun       Date:  2020-05-24       Impact factor: 3.575

Review 8.  The mechanistic basis of arsenicosis: pathogenesis of skin cancer.

Authors:  Katherine M Hunt; Ritesh K Srivastava; Craig A Elmets; Mohammad Athar
Journal:  Cancer Lett       Date:  2014-08-27       Impact factor: 8.679

9.  MINA controls proliferation and tumorigenesis of glioblastoma by epigenetically regulating cyclins and CDKs via H3K9me3 demethylation.

Authors:  M-Y Huang; F Xuan; W Liu; H-J Cui
Journal:  Oncogene       Date:  2016-06-13       Impact factor: 9.867

10.  Histone demethylase KDM2A promotes tumor cell growth and migration in gastric cancer.

Authors:  Yufeng Huang; Yiqian Liu; Lijiang Yu; Jing Chen; Juan Hou; Lihua Cui; De Ma; Wangkun Lu
Journal:  Tumour Biol       Date:  2014-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.